Quoin Pharmaceuticals Ltd (NASDAQ:QNRX)
| 1.32 Delayed Data As of 4:02pm ET |  0.00 / 0.00%Today’s Change | 1.13 Today|||52-Week Range 35.52 | -27.47% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $11.1M |
Company Description
Quoin Pharmaceuticals Ltd. is a specialty pharmaceutical company engages in the development of therapeutic products for the treatment of rare and orphan diseases. The company was founded on March 5, 2018 and is headquartered in Ashburn, VA.
Contact Information
Quoin Pharmaceuticals Ltd. 42127 Pleasant Forest Court Ashburn Virginia 20148-7349 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Michael Myers | Chairman & Chief Executive Officer |
| Denise Carter | Chief Operating Officer & Director |
| Gordon B. Dunn | Chief Financial Officer |
